Sonorheometry与旋转血栓弹力测量在创伤中的比较:诊断与预后性能对比
本研究在单一一级创伤中心2020至2021年纳入的209例成人创伤患者中,比较Quantra与ROTEM对创伤诱导性凝血病(TIC)的诊断及对输血需求和死亡的预测性能。Quantra与ROTEM参数相关性好,CS检测TIC的AUC高于EXTEM A5,而纤维蛋白原贡献检测低纤维蛋白原血症的AUC低于FIBTEM A5,两者在检测血小板减少、预测快速输血或6小时死亡方面无差异。
要点
- Quantra与ROTEM参数相关性好:CS与EXTEM A5的r=0.90,纤维蛋白原贡献与FIBTEM A5的r=0.85,血小板贡献与EXTEM-FIBTEM A5的r=0.73。
- CS检测TIC(INR>1.2)的AUC为0.83 vs EXTEM A5的0.79(p=.038),CS更高。
- 纤维蛋白原贡献检测纤维蛋白原<2g/L的AUC为0.79 vs FIBTEM A5的0.84(p=.027),FIBTEM A5更高。
核心结论
- Quantra与ROTEM在评估TIC和预测临床相关结局方面诊断性能相似。
- 需要更大规模研究来确定Quantra用于TIC目标导向治疗的效用。
研究设计与样本
- 样本来自2020至2021年间在一家一级创伤中心纳入的持续队列研究中的成人创伤患者,于入院时采集。
- 共分析209例患者的样本,使用Quantra、ROTEM、多电极聚集法和常规凝血试验进行分析。
主要发现
- Quantra与ROTEM参数相关性均强(均p<.001):CS与EXTEM A5的r=0.90,纤维蛋白原贡献与FIBTEM A5的r=0.85,血小板贡献与EXTEM-FIBTEM A5的r=0.73。
- 检测TIC(INR>1.2)时CS的AUC为0.83 vs EXTEM A5的0.79(p=.038),CS的区分能力更高。
- 检测低纤维蛋白原血症(纤维蛋白原<2g/L)时纤维蛋白原贡献的AUC为0.79 vs FIBTEM A5的0.84(p=.027),纤维蛋白原贡献的能力良好但低于FIBTEM A5。
- Quantra与ROTEM在检测血小板计数<150×10^9/L、预测快速输血或6小时死亡方面无差异。
局限性
- 需要更大规模研究来确定Quantra用于TIC目标导向治疗的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rotational thromboelastometry (ROTEM) is used to rapidly identify trauma-induced coagulopathy (TIC) and direct targeted interventions in hemorrhaging trauma patients. A novel technology, Quantra System (HemoSonics), utilizes sonic estimation of elasticity via resonance sonorheometry, avoids mechanical clot interference, and may increase diagnostic accuracy, but there are limited data on bleeding in major trauma patients. OBJECTIVES: To compare the performance of Quantra with that of ROTEM for rapid diagnosis of TIC and prediction of transfusion requirements and mortality. METHODS: Samples were collected from adult trauma patients enrolled in a perpetual cohort study upon admission to a single level 1 trauma center between 2020 and 2021. Samples were analyzed using Quantra, ROTEM, multiple electrode aggregometry, and conventional coagulation assays. RESULTS: Samples from 209 patients were analyzed. Correlations were strong between Quantra and ROTEM parameters (for all, p < .001): clot stiffness (CS) and tissue factor-activated ROTEM (EXTEM) clot amplitude at 5 minutes (A5) (r = 0.90); fibrinogen contribution to CS and tissue factor-activated ROTEM with cytochalasin D (FIBTEM) A5 (r = 0.85); and platelet contribution to CS and EXTEM-FIBTEM A5 (r = 0.73). Although CS showed higher discrimination than EXTEM A5 in detecting TIC (international normalized ratio, >1.2; area under the receiver operating characteristic curve, 0.83 vs 0.79; p = .038), the ability of fibrinogen contribution to CS to detect hypofibrinogenemia (a fibrinogen level of <2g/L) was good but lower than that of FIBTEM A5 (area under the receiver operating characteristic curve, 0.79 vs 0.84; p = .027). There was no difference between Quantra and ROTEM in detecting a platelet count of <150 × 109/L, predicting rapid transfusion or mortality at 6 hours. CONCLUSION: Quantra and ROTEM have similar diagnostic performances in evaluating TIC and predicting clinically relevant outcomes. Larger studies are required to determine the utility of Quantra for goal-directed treatment of TIC.
引用
- Rossetto A, Wohlgemut JM, Brohi K, et al. Sonorheometry versus rotational thromboelastometry in trauma: a comparison of diagnostic and prognostic performance. J Thromb Haemost. 2023. PMID: 37164268. doi:10.1016/j.jtha.2023.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。